Costello Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Costello Asset Management's BMY Position: Q2 2026 in Review
Costello Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 9.1% in Q2 2026, selling an estimated $5.74K and leaving 1,000 shares worth $57.6K. The position accounts for 0.02% of the portfolio, ranked #230.
Costello Asset Management first reported a position in BMY in Q2 2020 and has held it in 24 quarters since. The position peaked at $292K in Q4 2020. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Costello Asset Management held 1,000 shares of Bristol-Myers Squibb worth $57.6K as of Q2 2026.
- Costello Asset Management sold 100 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74K.
- Bristol-Myers Squibb made up 0.02% of Costello Asset Management's portfolio in Q2 2026, its #230 holding.
- Costello Asset Management first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 24 quarters since.
- Costello Asset Management's Bristol-Myers Squibb position peaked at $292K in Q4 2020.
- 954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.